Class ITerminatedD-0655-2020
Drug recall · January 22, 2020
Stallion Platinum 30000 Capsules in blue recall
Why: Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram paper packaging, packaged in 2, 4, 10 count blister cards, Motto International, Dallas, TX
- Lots / codes
All lots remaining within expiry.
- Quantity
- 7 boxes
- Company
- Motto International Corp, Dallas, TX
- Distribution
- TX
- Initiated
- December 17, 2019 · Voluntary: Firm initiated
- Classified
- January 10, 2020
- Reported
- January 22, 2020
- Ended
- October 29, 2021
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.